Roche Holding Ltd (RHHBY)

Drug Manufacturers - General

$55.69

+1.92 (+3.57%)

Last updated: Oct 14, 2026 at 5:00 PM ET

Earnings

Performance (10Y)

Beat Rate

44%(4/9)

Avg Surprise

-10.73%

Streak

2 Q

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2025Dec 25 Reported Jan 29, 2026Reported Jan 29	$1.36	$1.35	-	+0.74%	Beat	4	-	-6.2%
Jun 30, 2025Jun 25 Reported Jul 24, 2025Reported Jul 24	$1.74	$1.62	-	+7.41%	Beat	-	-	+52.6%
Dec 31, 2024Dec 24 Reported Dec 31, 2024Reported Dec 31	$0.35	N/A	-	-70.38%	Miss	-	-	-77.2%
Dec 31, 2023Dec 23 Reported Dec 31, 2023Reported Dec 31	$0.79	$1.22	-	-35.08%	Miss	-	-	-37.1%
Jun 30, 2023Jun 23 Reported Jul 27, 2023Reported Jul 27	$1.45	$1.49	-	-2.68%	Miss	-	-	+0.7%
Dec 31, 2022Dec 22 Reported Feb 2, 2023Reported Feb 2	$1.14	$1.19	-	-4.20%	Miss	-	-	-
Jun 30, 2022Jun 22 Reported Jul 21, 2022Reported Jul 21	$1.52	$1.41	-	+7.80%	Beat	-	-	-
Dec 31, 2021Dec 21 Reported Feb 3, 2022Reported Feb 3	$1.26	$1.32	-	-4.55%	Miss	-	-	-
Jun 30, 2021Jun 21 Reported Jul 22, 2021Reported Jul 22	$1.44	$1.38	-	+4.35%	Beat	-	-	-

Dividends

Dividend Metrics

Forward Yield2.78%

Forward Annual Dividend$1.55

FrequencyAnnual

Pay MonthsApr

Growth

3Y CAGR+3.17%

5Y CAGR+13.79%

RHHBY dividend history and ex-dividend dates Run RHHBY in the free DRIP calculator

Key Metrics

Valuation
P/E Ratio	17.96	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	N/A	Operating Margin	N/A
ROE	N/A	ROIC	22.69%
Financial Health
Debt/Equity	0.94x	Interest Coverage	18.65x
Current Ratio	1.38x	Quick Ratio	1.12x
Trading Statistics
Beta	N/A	Avg Volume	1.31M
52-Week High	N/A	52-Week Low	N/A

Technical Indicators Dashboard

Moving Averages

SMA 10$53.48

SMA 20$53.81

SMA 50$54.88

SMA 200$52.86

EMA 10$53.95

EMA 20$53.91

EMA 50$54.05

EMA 200$51.69

MACD

Line: -0.09Signal: -0.35Hist: 0.26

ADX

ADX: 13.1+DI: 32.5-DI: 20.2

Aroon & PSAR

Aroon Up12.0

Aroon Down60.0

PSAR$51.97

Bollinger Bands

Upper Band$56.22

Lower Band$51.41

%B Position895%(Upper)

Band Width0.89

RSI (14-Day)

Neutral

59.5

Momentum Oscillators

Stoch %K70.0

Stoch %D58.8

Williams %R-1.5

ROC (10d)7.3%

Momentum3.81

CCI (20d)103.8

MFI (14d)41.8

Volatility Measures

ATR (14d)$1.07(1.9%)

StdDev (20d)1.20

Hist Vol23.9%(Moderate)

Volume Flow

VWAP$55.33

OBV28.1M

AD Line-2.0B

CMF (20d)0.089

Volume Metrics

Avg Vol (20d)1.3M

Vol Ratio0.5x(Low)

VWMA (20d)$53.77

Pivot Points

R3$55.18

R2$54.88

R1$54.32

Pivot Point$54.02

S1$53.46

S2$53.16

S3$52.60

Advanced Oscillators

TSI-2.35

Ultimate Osc63.3

KST-27.81

Financial Data

Quarter	Dec 2025	Jun 2025	Dec 2024	Jun 2024	Dec 2023	Jun 2023	Dec 2022	Jun 2022	Dec 2021	Jun 2021	Dec 2020	Jun 2020
Total Revenue	$30.32B	$15.92B	$31.64B	$30.76B	$30.66B	$29.78B	$30.99B	$32.30B	$32.09B	$30.71B	$29.04B	$29.28B
Cost of Revenue	$8.57B	$3.87B	$8.81B	$7.47B	$8.28B	$7.54B	$9.09B	$9.75B	$10.47B	$9.24B	$8.45B	$7.91B
Gross Profit	$21.75B	$12.05B	$22.83B	$23.28B	$20.66B	$22.24B	$21.90B	$22.55B	$21.62B	$21.47B	$20.59B	$21.37B

Operating Expenses	$14.70B	$6.88B	$18.48B	$14.21B	$13.77B	$12.78B	$13.99B	$12.27B	$13.57B	$12.25B	$12.71B	$11.53B
R&D	$6.62B	$3.34B	$6.77B	$7.39B	$6.94B	$6.29B	$7.42B	$6.63B	$7.02B	$6.69B	$6.37B	$5.79B
SG&A	$8.08B	$3.29B	$7.25B	$6.46B	$6.71B	$6.39B	$6.46B	$5.57B	$6.42B	$5.46B	$6.20B	$5.63B
Operating Income	$7.05B	$5.17B	$4.35B	$9.07B	$5.94B	$9.46B	$7.90B	$10.27B	$8.05B	$9.23B	$7.88B	$9.84B

Interest Income	$0	$0	$0	$0	$294.00M	$339.00M	$314.00M	$254.00M	$174.00M	$3.00M	$2.00M	$14.00M
Interest Expense	$734.88M	$247.50M	$623.00M	$632.01M	$423.00M	$405.00M	$350.00M	$258.00M	$170.00M	$171.00M	$209.00M	$229.00M
Income Before Tax	$7.32B	$4.79B	$3.54B	$8.25B	$4.89B	$9.17B	$5.37B	$11.00B	$7.51B	$9.89B	$7.79B	$10.18B
Income Tax Expense	$1.41B	$878.00M	$1.08B	$1.53B	$55.00M	$1.61B	$972.00M	$1.82B	$792.00M	$1.67B	$1.18B	$1.72B

Net Income	$5.42B	$3.71B	$2.02B	$6.26B	$4.36B	$7.14B	$3.89B	$8.53B	$6.13B	$7.80B	$6.22B	$8.08B

EBITDA	$15.18B	$6.53B	$6.09B	$10.53B	$7.07B	$11.34B	$10.14B	$13.16B	$9.86B	$12.33B	$10.37B	$12.61B
EBIT	$12.56B	$5.75B	$4.32B	$8.88B	$5.35B	$9.59B	$8.36B	$11.26B	$7.68B	$10.06B	$7.99B	$10.41B

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about RHHBY

News

No news available

Company news will appear here when available

RHHBY Valuation and Fair Value

P/E: 18.0x

See GNG's fair value

RHHBY Profitability: Margins, ROIC and FCF

Gross margin: 73.1%
ROIC: 22.7%

RHHBY Competitors

Company	Ticker
Metsera, Inc. Common Stock	MTSR
Genfit S.A.	GNFT
STRATA Skin Sciences Inc	SSKN
Jasper Therapeutics Inc	JSPRW
Protagenic Therapeutics Inc	PTIXW
NeuroSense Therapeutics Ltd. Warrant	NRSNW
P3 Health Partners Inc	PIIIW
Celularity Inc	CELUW

Sector: Healthcare

RHHBY Bull Case vs Bear Case

Bull case

RHHBY earns a 22.7% return on invested capital.

Bear case

RHHBY beat EPS estimates in 37.5% of its last 8 reported quarters.

RHHBY Earnings: Beat Rate and Next Report

Beat rate: 3 of 8 quarters (37.5%)
Average surprise: -12.6%

RHHBY Dividend

Forward yield: 2.8%
3Y DPS growth: 3.2%
5Y DPS growth: 13.8%
Pay months: Apr

RHHBY dividend history

Frequently Asked Questions About RHHBY

What is RHHBY's current dividend yield?

Roche Holding Ltd (RHHBY) has a forward dividend yield of 2.78%.

Does RHHBY pay dividends?

Yes, Roche Holding Ltd pays dividends with a forward dividend yield of 2.78%.

What is RHHBY's P/E ratio?

Roche Holding Ltd has a price-to-earnings (P/E) ratio of 17.96.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In